VRAY - ビュ―レイ (ViewRay Inc.) ビュ―レイ

 VRAYのチャート


 VRAYの企業情報

symbol VRAY
会社名 ViewRay Inc (ビュ―レイ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 ビューレー(ViewRay Inc.)はがん患者のイメージングと治療を同時に行う磁気共鳴イメージング(MRI)誘導放射線治療システムであるMRIdianを設計・製造・販売する。MRIdianは、MRI技術、放射線送達およびそのソフトウェアを統合して、放射線が送達されている間に軟部組織腫瘍の位置・形状を見つけ、標的にし、追跡する。MRIdianはまた、治療領域が受けた放射線量のレベルを記録し、医師が必要に応じて治療間で処方を適合させることを可能にする。同社はMRIdianを、大学の研究および教育病院、地域病院、私立診療所、政府機関、自立した癌センターなど、多数の顧客に販売する。また、MRIdian Linacと呼ばれるMRIdian技術のリニアアクセラレータ、またはリニアックバージョンの開発に従事する。   ビュ―レイは米国の医療機器メ―カ―。同社と全額出資子会社ビュ―レイ・テクノロジ―ズは、MRI画像に導かれた放射線治療システム機器「MRIdian」の開発・製造・販売に従事。がん腫瘍をMRI画像で特定すると同時に放射線治療を行うため、周囲の臓器や細胞に与える負担を軽減することができる。本社はオハイオ州オ―クウッドビレッジ。   ViewRay, Inc., designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
本社所在地 2 Thermo Fisher Way Oakwood Village OH 44146 USA
代表者氏名
代表者役職名
電話番号 +1 440-703-3210
設立年月日 41518
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 139人
url www.viewray.com
nasdaq_url https://www.nasdaq.com/symbol/vray
adr_tso
EBITDA EBITDA(百万ドル) -51.22900
終値(lastsale) 9.225
時価総額(marketcap) 865815742.125
時価総額 時価総額(百万ドル) 794.01640
売上高 売上高(百万ドル) 74.75000
企業価値(EV) 企業価値(EV)(百万ドル) 772.47240
当期純利益 当期純利益(百万ドル) -65.39400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Viewray Inc revenues increased from $1.9M to $42.6M. Net loss applicable to common stockholders decreased 19% to $29.5M. Revenues reflect Product increase from $0K to $40.7M. Lower net loss reflects Other income (expense) net increase from $9.1M (expense) to $6.5M (income) Interest income increase of 100% to $4K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.69 to -$0.40.

 VRAYのテクニカル分析


 VRAYのニュース

   ViewRay Inc. Shares Close the Day 13.8% Higher - Daily Wrap  2021/05/07 22:30:00 Kwhen Finance
ViewRay Inc. (VRAY) shares closed today 13.8% higher than it did at the end of yesterday. The stock is currently up 25.1% year-to-date, up 188.0% over the past 12 months, and up 2.1% over the past five years. Today, the Dow Jones Industrial Average rose 0.7%, and the S&P 500 rose 0.7%. Trading Activity Shares traded as high as $5.51 and as low as $4.56 this week.Shares closed 3e+1% below its 52-week high and 2e+2% above its 52-week low.Trading volume this week was 138.1% higher than the 10-day average and 175.8% higher than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 10.1% higher than its 5-day moving average, 18.1% higher than its 20-day moving average, and 15.0% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 171.3% The company's stock price performance over the past 12 months beats the peer average by 236.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference  2021/03/05 21:01:00 PR Newswire
CLEVELAND, March 5, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) (the "Company") today announced that members of management will be participating in the 21st Annual Oppenheimer Healthcare Conference on Tuesday, March 16, 2021. ViewRay will be conducting a virtual fireside chat at…
   A Preview Of ViewRay's Earnings  2021/03/03 10:39:00 Benzinga
ViewRay (NASDAQ:VRAY) announces its next round of earnings this Thursday, March 04. Here is Benzinga's look at ViewRay's Q4 earnings report. Net …
   Penn State Health Purchases Second ViewRay MRIdian® Linac  2021/02/11 11:30:00 PR Newswire
CLEVELAND, Feb. 11, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Penn State Health has purchased a second MRIdian Linac joining other pioneering institutions from around the globe investing in multiple MRIdian systems. Penn State Health's first MRIdian Linac will…
   ViewRay Announces Participation in the B. Riley Oncology Investor Conference  2021/01/15 13:30:00 PR Newswire
CLEVELAND, Jan. 15, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) (the "Company") today announced that members of management will be participating in a fireside chat at the B. Riley Oncology Investor Conference on Wednesday, January 20, 2021. ViewRay will also be hosting 1x1 meetings…
   ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock  2021/01/07 21:01:00 PR Newswire
CLEVELAND, Jan. 7, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the completion of its previously announced underwritten public offering of…
   ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference  2021/03/05 21:01:00 PR Newswire
CLEVELAND, March 5, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) (the "Company") today announced that members of management will be participating in the 21st Annual Oppenheimer Healthcare Conference on Tuesday, March 16, 2021. ViewRay will be conducting a virtual fireside chat at…
   A Preview Of ViewRay's Earnings  2021/03/03 10:39:00 Benzinga
ViewRay (NASDAQ:VRAY) announces its next round of earnings this Thursday, March 04. Here is Benzinga's look at ViewRay's Q4 earnings report. Net …
   Penn State Health Purchases Second ViewRay MRIdian® Linac  2021/02/11 11:30:00 PR Newswire
CLEVELAND, Feb. 11, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Penn State Health has purchased a second MRIdian Linac joining other pioneering institutions from around the globe investing in multiple MRIdian systems. Penn State Health's first MRIdian Linac will…
   ViewRay Announces Participation in the B. Riley Oncology Investor Conference  2021/01/15 13:30:00 PR Newswire
CLEVELAND, Jan. 15, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) (the "Company") today announced that members of management will be participating in a fireside chat at the B. Riley Oncology Investor Conference on Wednesday, January 20, 2021. ViewRay will also be hosting 1x1 meetings…
   ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock  2021/01/07 21:01:00 PR Newswire
CLEVELAND, Jan. 7, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the completion of its previously announced underwritten public offering of…

 関連キーワード  (先端医療機器_テクノロジ― 米国株 ビュ―レイ VRAY ViewRay Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)